ARCHIVES

ODAC votes 9-6 in favor of Clolar for pediatric acute lymphoblastic leukemia, but votes against Marqibo for non-Hodgkin’s lymphoma.

This article is from The Cancer Letter archive.

Vol. 30 No. 46 | December 10, 2004

Download PDF Visit The Full Archive

Related Articles

In Brief: Olden Chosen To Head NIEHS; Cancer Panel To Discuss Cancer and Poverty On July 9

June 28, 1991

Federal Regs Prohibit RFP Budget Releases

February 21, 1975

Newest NIH Institute, NIBIB, Gets An Acting Director.

May 11, 2001

Board of Scientific Advisors discussion: Are peer reviewers correctly interpreting the guidelines?

March 19, 2004

Cancer Prevention: HHS Calls for Warning Labels on Cigars, Says Teen Use High

March 5, 1999

DeVita Dissatisfied With Cooperative Groups on Accrual; NCAB to Hear Wittes’ Plan In Feb.

November 20, 1987